Holders over time
- THC
- ELV
| Quarter | THC | ELV |
|---|---|---|
| Q3 2020 | 4 holders, $722m | 30 holders, $15.0bn |
| Q4 2020 | 9 holders, $1.2bn | 29 holders, $16.7bn |
| Q1 2021 | 9 holders, $1.3bn | 25 holders, $18.6bn |
| Q2 2021 | 10 holders, $1.6bn | 30 holders, $19.4bn |
| Q3 2021 | 12 holders, $1.8bn | 26 holders, $18.5bn |
| Q4 2021 | 11 holders, $2.1bn | 29 holders, $23.3bn |
| Q1 2022 | 15 holders, $2.7bn | 31 holders, $23.9bn |
| Q2 2022 | 14 holders, $1.7bn | 32 holders, $23.3bn |
| Q3 2022 | 11 holders, $1.6bn | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $1.1bn | 34 holders, $25.5bn |
| Q1 2023 | 17 holders, $1.1bn | 39 holders, $22.5bn |
| Q2 2023 | 24 holders, $1.7bn | 38 holders, $20.6bn |
| Q3 2023 | 23 holders, $1.7bn | 34 holders, $19.8bn |
| Q4 2023 | 18 holders, $2.0bn | 36 holders, $20.3bn |
| Q1 2024 | 19 holders, $3.1bn | 35 holders, $21.3bn |
| Q2 2024 | 25 holders, $4.2bn | 33 holders, $22.1bn |
| Q3 2024 | 26 holders, $5.2bn | 30 holders, $20.2bn |
| Q4 2024 | 20 holders, $3.6bn | 32 holders, $15.9bn |
| Q1 2025 | 20 holders, $4.2bn | 28 holders, $17.1bn |
| Q2 2025 | 25 holders, $5.3bn | 27 holders, $14.8bn |
| Q3 2025 | 25 holders, $5.6bn | 27 holders, $12.7bn |
| Q4 2025 | 22 holders, $5.6bn | 25 holders, $17.0bn |
| Q1 2026 | 22 holders, $5.2bn | 26 holders, $13.6bn |
| Q2 2026 | 15 holders, $3.8bn | 28 holders, $17.7bn |
Tenet Healthcare Corp
- Holders
- 25
- Reported value
- $5.3bn
- Buyers
- 13
- Sellers
- 11
Breadth +2 among 95 comparable managers.
Elevance Health Inc Formerly
- Holders
- 27
- Reported value
- $14.8bn
- Buyers
- 13
- Sellers
- 16
Breadth -3 among 95 comparable managers.
Who holds both, Q2 2025
Both (12)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Harris Associates LP, Invesco Ltd, T. Rowe Price Associates Inc
Only THC (13)
Citadel Advisors LLC, Farallon Capital Management LLC, Freestone Grove Partners LP, Glenview Capital Management LLC, Holocene Advisors LP, Marshall Wace LLP, Maverick Capital Ltd, Millennium Management LLC, Point72 Asset Management LP, Schonfeld Strategic Advisors LLC, Voloridge Investment Management LLC, Walleye Capital LLC, Woodline Partners LP
Only ELV (15)
Acadian Asset Management LLC, Artisan Partners LP, Baillie Gifford & Co, Baupost Group LLC, Capital Research Global Investors, D1 Capital Partners LP, Dodge & Cox, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Moore Capital Management LP, Ruane Cunniff & Goldfarb LP, Squarepoint Ops LLC, Two Sigma Investments LP, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.